Related Experiment Video
Updated: Jun 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
The role of statins in stroke
1Division of Internal Medicine, ASL 1 Umbria, via Engels-Voc.Chioccolo, 06012 Città di Castello (Perugia), Italy. ugo.paliani@ASLasl1.umbria.it
Statin therapy significantly reduces stroke risk in both primary and secondary prevention, even with elevated cholesterol or hs-CRP. Clinical trials confirm statins
Area of Science:
- Cardiovascular Medicine
- Neurology
- Pharmacology
Background:
- Epidemiological studies suggest a link between cholesterol levels and stroke risk, though evidence is not definitive.
- Clinical trials for coronary benefits of statins provide compelling evidence for their role in reducing stroke risk.
- Stroke pathophysiology differs from heart attack, necessitating specific trials to confirm statin efficacy and risks in stroke patients.
Purpose of the Study:
- To evaluate the efficacy of statin therapy in stroke prevention.
- To assess the benefits and risks of statins in primary and secondary stroke prevention populations.
Main Methods:
- Analysis of clinical therapy trials, including those primarily designed for coronary benefits.
- Review of specific trials conducted in stroke patient populations.
- Examination of statin effectiveness in primary prevention based on low-density lipoprotein (LDL) and hs-CRP levels.
Main Results:
- Statin therapy demonstrates a reduction in stroke risk.
- In primary prevention, statins are effective for individuals with elevated LDL or hs-CRP.
- In secondary prevention, statins achieve an absolute reduction in recurrent stroke, with a number needed to treat of 45 over 5 years.
Conclusions:
- Statin therapy is beneficial for reducing stroke risk across different patient populations.
- Statins offer advantages in both primary and secondary stroke prevention.
- The findings support the use of statins for stroke risk reduction, supported by robust clinical trial data.
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis III: Management
Ischemic Stroke ll: Pathophysiology
Atherosclerosis IV: Nursing Management
Ischemic Stroke l: Introduction
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...